In EOC, Inaba et al. showed that high IDO expression in the tumor cells correlated with a reduced number of CD8+ tumor-infiltrating lymphocytes (TILs) and that administration of an IDO inhibitor decreased the tumor peritoneal dissemination [26]. This evidence concerns the gene IDO1 and neoplasm.